The Bangalore Sales Corporation

Sucralfate IP Powder is a pharmaceutical-grade active ingredient used primarily in the manufacture of medications for the treatment of gastric and duodenal ulcers. It is supplied in compliance with Indian Pharmacopoeia (IP) standards and is valued for its protective and healing action on the gastrointestinal mucosa.

Key Features and Specifications

• Chemical Name: Sucralfate

• CAS Number: 54182-58-0

• Molecular Formula: C12H54Al16O75S8

• Molecular Weight: ~2086 g/mol

• Pharmacopoeia Grade: IP (Indian Pharmacopoeia)

• Appearance: White or almost white, amorphous, odorless powder

• Solubility: Insoluble in water, ethanol, and chloroform; swells in water to form a viscous, adhesive suspension

• pH (1% suspension): 3.5–4.5

• Assay (as dried substance): Typically not less than 98.0% and not more than 102.0% (on dried basis)

• Loss on Drying: Not more than 10.0%

Pharmacological Properties & Uses

• Class: Gastroprotective agent; complex of sucrose octasulfate and aluminium hydroxide

• Mechanism of Action: Forms a protective, viscous barrier at the ulcer site by binding to proteins in the ulcer base and exudate, shielding the mucosa from gastric acid, pepsin, and bile salts; also promotes local regeneration and healing.

• Primary Indications:

  • Management and treatment of duodenal and gastric ulcers

  • Adjunct therapy for gastroesophageal reflux disease (GERD)

  • Erosive gastritis, oral and esophageal ulcers, stress ulcer prophylaxis

• Formulation Use: Used in the manufacture of oral suspensions, tablets, and other solid dosage forms.

Packaging & Storage

• Packaging: Typically 25 kg fiber drums with double polyethylene inner liners

• Shelf Life: Usually 2–3 years when stored as recommended

• Storage Conditions: Store in a cool, dry place, in tightly closed containers, protected from light and moisture

Summary Table: Sucralfate IP API Powder

Note:
Sucralfate IP powder is intended strictly for use in pharmaceutical manufacturing and must be processed into finished dosage forms for clinical use. Not for direct human consumption as a raw material.

    

 

Thiamine Hydrochloride (Thiamine HCl) is a water-soluble form of Vitamin B1, essential for maintaining healthy metabolism, nervous system function, and cellular energy production. This high-purity, pharmaceutical-grade powder is widely used in dietary supplements, food fortification, and pharmaceutical formulations.

Key Benefits:

• Supports carbohydrate metabolism and energy production

• Promotes healthy nerve and brain function

• Contributes to heart and muscle health

• Essential for cellular growth and repair

Product Features:

• ≥ 99% purity (HPLC tested)

• White to off-white crystalline powder

• Odorless and water-soluble

• Complies with USP / BP / EP standards

• Free from GMOs, gluten, and artificial additives

Packaging Details:

Applications:
Ideal for use in nutraceuticals, vitamin premixes, functional foods, beverages, and pharmaceutical preparations.

Ceftriaxone Powder API Product Description

Ceftriaxone is a third-generation, broad-spectrum cephalosporin antibiotic active pharmaceutical ingredient (API) widely used for formulating injectable sterile products. It is primarily supplied as a sterile sodium salt powder for intravenous or intramuscular administration.

Key Features

• Chemical Name: Ceftriaxone sodium

• CAS Numbers: 73384-59-5 (Ceftriaxone), 104376-79-6 (Ceftriaxone sodium)

• Molecular Formula: C18H16N8Na2O7S3 · 3.5H2O

• Molecular Weight: 661.6 g/mol (anhydrous)

• Appearance: White to yellowish, sterile crystalline powder

• Solubility: Highly soluble in water, sparingly soluble in methanol, very slightly in ethanol

• Assay (Purity): Typically ≥99% (often specified as minimum 795 µg/mg for ceftriaxone sodium)

• pH (1% aqueous solution): ~6.7

• Common Packaging: 5–25 kg sterile tins/drums

Pharmacological Profile

• Class: Third-generation cephalosporin; β-lactam antibiotic

• Mechanism: Inhibits bacterial cell wall synthesis, demonstrating potent, broad-spectrum bactericidal activity

• Half-Life: Relatively long, allowing convenient once or twice-daily dosing

• Spectrum: Effective against many Gram-positive and Gram-negative bacteria, except for certain resistant organisms and methicillin-resistant Staphylococcus aureus

Main Applications and Indications

Ceftriaxone API is formulated chiefly for injectable products indicated in:

• Respiratory tract infections (pneumonia, bronchitis)

• Skin and soft tissue infections

• Urinary tract infections (UTI)

• Gonorrhea (including uncomplicated)

• Pelvic inflammatory disease (PID)

• Ear infections (otitis media)

• Sepsis (blood infections)

• Bone and joint infections

• Intra-abdominal infections

• Meningitis (bacterial)

• Surgical prophylaxis

• Lyme disease

Stability and Storage

• Preferred Conditions: Store in original, tightly sealed containers at controlled room temperature (15–25°C), protected from moisture and light

• Shelf Life: Usually specified per batch based on regulatory data

Regulatory & Quality Notes

• Manufactured under cGMP with available documentation such as CEP, US-DMF, or equivalent certificates

• Free from added excipients, as required for injectable APIs

Summary Table: Ceftriaxone API Powder

Note: This API is strictly intended for pharmaceutical manufacturing of sterile injectable dosage forms and must be handled according to sterile, regulatory guidelines. It is not intended for direct consumer use.

Sildenafil Citrate API Powder is a pharmaceutical-grade active ingredient primarily used in the formulation of medications to treat erectile dysfunction and pulmonary arterial hypertension. It is supplied as a high-purity, white to off-white crystalline powder in compliance with major pharmacopeial standards (IP/USP).

 

Key Features:

• Chemical Name: 1-[[3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate

• CAS Number: 171599-83-0

• Molecular Formula: C22H30N6O4S·C6H8O7 (often presented as C28H38N6O11S for the citrate salt)

• Molecular Weight: ~666.7 g/mol

• Appearance: White to off-white crystalline powder

• Purity (Assay): ≥99% (pharmaceutical/API grade)

• Solubility: Freely soluble in DMSO and ethanol; slightly soluble in water

• Melting Point: 186–192°C

• Grade: IP/USPMedicine grade

• Shelf Life: 2–5 years under recommended storage

• Storage: Store in a cool, dry place away from moisture and light; deep freeze at -20°C for long-term storage

Pharmacological & Therapeutic Information:

• Therapeutic Class: Phosphodiesterase type 5 (PDE5) inhibitor

• Mechanism of Action: Inhibits PDE5, increasing cyclic GMP and mediating vascular smooth muscle relaxation, enabling improved blood flow particularly in the corpus cavernosum (penis) and pulmonary vasculature.

• Primary Uses:

  • Treatment of erectile dysfunction (impotence) in adult males

  • Treatment of pulmonary arterial hypertension (PAH)

• Formulation Uses: Used for manufacturing oral solid dosage forms (e.g., tablets, capsules) and occasionally for extemporaneous suspensions.

Quality and Compliance:

• COA (Certificate of Analysis) and MSDS (Material Safety Data Sheet) provided with each batch.

Packaging:

• Standard bulk packaging: 25 kg double poly bags in HDPE drum (other sizes available upon request)

• Immediate shipment from ready stock; export-worthy packaging suitable for global markets.

Summary Table: Sildenafil Citrate API Powder

Note:
Sildenafil Citrate API powder is strictly intended for pharmaceutical manufacturing. It must be processed into finished dosage forms in compliance with regulatory requirements before clinical use

Zopiclone IP Powder is a pharmaceutical-grade active pharmaceutical ingredient (API) used in the manufacture of medications for the short-term treatment of insomnia. It is produced under strict quality controls compliant with Indian Pharmacopoeia (IP) standards and is supplied as a high-purity, white crystalline powder.

Key Features and Specifications

• Chemical Name: Zopiclone

• CAS Number: 43200-80-2

• Molecular Formula: C17H17ClN6O3

• Molecular Weight: 388.8 g/mol

• Grade: IP (Indian Pharmacopoeia) 

• Purity (Assay): ≥99%

• Appearance: White or almost white crystalline powder

• Solubility: Slightly soluble in water; soluble in methylene chloride, sparingly soluble in ethanol

• Packaging: Typically supplied in 25 kg bags or drums for bulk pharmaceutical manufacturing

Pharmacological Profile

• Therapeutic Class: Nonbenzodiazepine hypnotic (cyclopyrrolone class)

• Mechanism of Action:

  • Acts as a GABA-A receptor agonist, binding primarily to the omega-1 subtype of the benzodiazepine receptor complex.

  • Facilitates the opening of chloride channels, causing hyperpolarization of neuronal membranes, resulting in CNS depression and promotion of sleep.

• Primary Effects: Hypnotic and sedative, with minimal anxiolytic effect.

Main Applications

• Indication: Short-term management of insomnia (difficulties with sleep initiation, frequent awakenings, or early morning arousals).

• Formulations: Used as the API for manufacturing immediate-release and other dosage form tablets for oral administration.

Quality & Regulatory

• Compliance: Manufactured as per IP and may comply with BP/EP/USP specifications as required.

• Documentation & Certification: Accompanied by full regulatory documentation including certificate of analysis (CoA) and, where necessary, Drug Master Files (DMFs).

Safety & Handling

• Storage: Store in a tightly closed container in a cool, dry place, protected from light and moisture.

• Use: Intended strictly for pharmaceutical manufacturing; not for direct human consumption in raw form.

Summary Table: Zopiclone IP API Powder

Note:
Zopiclone IP Powder is a controlled pharmaceutical ingredient strictly intended for use by licensed manufacturers in the preparation of finished medicines for the management of sleep disorders. It should only be handled by trained professionals in accordance with regulatory guidelines

L-Ornithine L-Aspartate Powder Product Description

L-Ornithine L-Aspartate (LOLA) Powder is a pharmaceutical and nutraceutical ingredient, primarily valued for its role in liver support and ammonia detoxification. It is a stable, highly soluble, white to off-white crystalline powder composed of two naturally occurring amino acids—L-ornithine and L-aspartic acid—processed into a salt for oral or parenteral formulations.

Key Characteristics

• Chemical Name: L-Ornithine L-Aspartate

• Synonyms: Ornithine aspartate, LOLA, L-Ornithine-L-aspartate salt

• CAS Number: 3230-94-2

• Molecular Formula: C9H19N3O6

• Molecular Weight: 265.26 g/mol

• Physical Appearance: White to off-white, odorless, crystalline powder

• Assay (Purity): ≥98%

• Solubility: Highly soluble in water, slightly soluble in alcohol

• Melting Point: ~210–220°C (decomposes)

• Packaging: Commonly supplied in 25 kg drums for bulk/pharmaceutical use

Main Applications

• Pharmaceutical Ingredient:

  • Used as an active pharmaceutical ingredient (API) in the treatment of hepatic encephalopathy (declining brain function due to advanced liver disease) by lowering elevated blood ammonia levels.

• Nutraceutical Support:

  • Included in dietary supplements to support liver function, detoxification, and energy metabolism.

• Adjunct Therapy:

  • Beneficial in chronic liver diseases such as cirrhosis, hepatitis, and fatty liver, often used as adjunct therapy to enhance recovery and decrease fatigue.

• Performance Nutrition:

  • Sometimes found in sports supplements for potentially reducing ammonia build-up and supporting quicker muscle recovery.

Stability & Storage

• Shelf Life: 3 years when stored properly

• Storage Conditions: Store at room temperature (ideally -20°C for maximum shelf life), in a sealed container, away from moisture and light.

Regulatory & Safety Notes

• Grade: Available in pharmaceutical, food, and technical grade

• Toxicity: Well-tolerated within prescribed doses (up to 18 grams/day for up to 6 months considered generally safe)

• Intended Use: For use in manufacturing of medicines or supplements—final dosing or administration should be directed by a healthcare professional.

Summary Table: L-Ornithine L-Aspartate Powder

Summary:
L-Ornithine L-Aspartate Powder, with its superior solubility and high purity, is a preferred ingredient for liver health formulations, hepatic encephalopathy management, and as a supportive nutraceutical in metabolic and chronic liver disorders